| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/03/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/15/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 11/15/2021 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/16/2019 |
4
| Bill & Melinda Gates Foundation (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Converted 2,777,777 shares
@ $0
Converted 2,222,222 convertible preferred
@ $0
Converted 555,555 convertible preferred
@ $0 |
|
| 10/10/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
3
| Bill & Melinda Gates Foundation (10% Owner) has filed a Form 3 on Atreca, Inc. |
| 03/15/2019 |
SC 13G
| Bill & Melinda Gates Foundation reports a 1.8% stake in X4 Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/01/2018 |
4
| Bill & Melinda Gates Foundation (10% Owner) has filed a Form 4 on Liquidia Technologies Inc|
Txns:
| Converted 797,073 shares
@ $0
Converted 11,286,115 preferred shares
@ $0 |
|
| 07/25/2018 |
3
| Bill & Melinda Gates Foundation (10% Owner) has filed a Form 3 on Liquidia Technologies Inc |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/20/2017 |
4
| Bill & Melinda Gates Foundation (10% Owner) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Converted 722,179 shares
@ $0
Converted 2,464,799 convertible preferred
@ $0 |
|
| 11/15/2017 |
3
| Bill & Melinda Gates Foundation (10% Owner) has filed a Form 3 on Arsanis, Inc. |